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Abstract
Previous studies performed in the laboratory have shown that nitrogen narcosis induces a decrease in striatal
glutamate and dopamine levels. Although we stimulated the N-methyl-D-aspartate (NMDA) receptor, an important
glutamate receptor required for motor and locomotor activity managed by the striatum, and demonstrated that
the receptor was effective when exposed to nitrogen at 3MPa, it was not possible to return the striatal glutamate
level to its base values. We conclude that it was the striatopetal neurons of the glutamatergic pathways that were
mainly affected in this hyperbaric syndrome, without understanding the principal reasons. Hence we sought to
establish what happens in the vicinity of the plasma membrane, downstream the NMDA-Receptor, and we used
the hypothesis that there could be neuronal nitric oxide synthase (nNOS) disturbances. A microdialysis study was
performed in rat striatum in order to analyse levels of citrulline, the NO co-product, and arginine, the NO precursor.
Those both NO metabolites were detectable with an HPLC coupled to a fluorimetric detector. Exposure to
pressurized nitrogen induced a reduction in citrulline (-18.9%) and arginine (-10.4%) levels. Under the control
normobaric conditions, the striatal NMDA infusion enhanced the citrulline level (+85.6%), whereas under 3 MPa of
nitrogen, the same NMDA infusion did not change the citrulline level which remains equivalent to that of the
baseline. The level of arginine increased (+45.7%) under normobaric conditions but a decrease occurred in
pressurized nitrogen (-51.6%). Retrodialysis with Saclofen and KCl in the prefrontal cortex under normobaric
conditions led to an increase in striatal levels of citrulline (+30.5%) and a decrease in arginine levels (-67.4%). There
was no significant difference when nitrogen at 3MPa was added. To conclude, the synthesis of citrulline/NO is
reduced in nitrogen narcosis while it seems possible to activate it artificially by infusion. We have suggested that
the low glutamate levels recorded in nitrogen narcosis induced these dopamine and NO reductions in the
striatum.
Introduction
Considering motor and locomotor dysfunctions occurring
under the effect of nitrogen narcosis [1], also known as
diver’s staggers, previous studies conducted at the end of
the 1990s logically focused on the dopaminergic transmis-
sion in the rat striatum. A decrease in striatal dopamine
levels was highlighted [1,2]. And yet, the control of motor
and locomotor activity by the striatum requires dopami-
nergic as much as glutamate receptors. Hence, the logical
follow-on from the earlier work was to extend the research
to this other main neurotransmitter-glutamate-and its
regulatory pathways, particularly as Abraini [3] had early
suggested that inert gases under pressure may act on pro-
tein receptors such as the NMDA (N-methyl D-Aspartate)
Receptor, a glutamate receptor. Hence our investigation
described a decrease in striatal glutamate levels in rats
subjected to nitrogen under pressure [4]. The logical con-
sequence was to test proximal and distal stimulation of
the striatal glutamate release (Figure 1), but no improve-
ment was observed in relation to rat behavioural disorders.
In fact, neither the intrastriatal NMDA infusion nor the
KCl-mPFC (motor Prefrontal Cortex area) stimulation was
effective in rectifying the nitrogen-induced glutamate
reduction in the striatum [5,6]. Nevertheless, we demon-
strated that the NMDA-receptor remains functional in the
striatum, like in the substantia nigra [7,8], under the effect
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any medium, provided the original work is properly cited.of nitrogen narcosis, as it increases extracellular dopamine
levels. Even so, the increased effect on glutamate release
noted under atmospheric pressure disappeared under
pressurized nitrogen. We suspected a disturbance close to
the plasma membrane on the intracellular side, behind the
NMDA-receptor and we decided to focus on Nitric Oxide
(NO). In fact, nitrogen under pressure has even been sug-
gested by Vjotosh et al. in 1999 [9] to affect nitric oxide
(NO) synthesis. We are the first to describe NO develop-
ment under nitrogen narcosis.
Actually, the retrograde action of endogenous NO is
known to regulate the synaptic level of various neuro-
transmitters [8-15] by modulating endocytosis, vesicle
maturation [14] and the opening frequency of the
NMDA-receptor [16]. For instance, a molecular analysis
had revealed a direct action site for NO on the NMDA-
receptor [16]. Besides, the neuronal NO Synthase
(nNOS) produces NO almost exclusively after activation
of the NMDA receptor [17-19]. The gaseous neuronal
messenger in turn modulates glutamate transmission
[20-24], but this is not all. NO diffusion is also known
to modulate DA release in the striatum [15,25,26].
NO is synthesized from a unique precursor, arginine
[27,28], by NO synthase (NOS) (see Garthwaite & Boulton
[25] for review). NOS produces as much NO from argi-
nine as it does the by-product, citrulline. The entire citrul-
line-NO cycle [29], which consists of an enzymatic recycle
of arginine from citrulline, is present in the striatum
[30-33].
The aim of this study was to check whether neuronally
derived NO levels were changed under nitrogen narcosis,
and what was the influence of this change on extracellular
striatal glutamate and dopamine concentration. Arginine
and citrulline concentrations were measured by microdia-
lysis, and compared with glutamate and dopamine devel-
opments whether the striatum was stimulated or not. Our
hypothesis was that a reduction in striatal glutamate and
dopamine levels recorded under the effect of nitrogen nar-
cosis could be coupled with a decrease in arginine and
citrulline levels, the precursor and the co-product of NO.
These metabolites measurable by a fluorimetric HPLC
should reflect the NO synthesis. Complementary results of
this study, essentially concerning dopamine and glutamate
levels, have been presented in previous papers [4-6].
Materials and methods
Animals and ethical approval
All procedures for the use of animals were in accordance
with the Council of the European Union rules (Brussels,
Belgium), Directive of November 24, 1986 (86/609/EEC),
as stated in French law (Decree 87/848), and experiments
were conducted in accordance with the policies of our
Institutional Animal Care and Use Committee (associated
with Agreement Number: B13.0005.8). Male Sprague-
Dawley rats (Charles River, France) weighing 300-350 g
were used (n = 46). The rats were kept at 22 ± 1 °C in a
12-hour light/12-hour dark cycle (lights on at 7:00 a.m.)
with food (A03, UAR) and water available ad libitum.
After surgery, the rats were housed individually in Plexi-
glass
® cages where they recovered for at least a week
before undergoing the microdialysis procedure.
The animals were divided into 6 groups. The first group
(_1_), using helium at 3MPa (n = 8), needs to be com-
pared to the second one (_2_) developed under nitrogen
at 3MPa (n = 6). The aim was to dissociate the narcotic
potency of nitrogen from the effect of the pressure per se.
At this pressure, the narcotic potency of helium is very
low. Hence, at the same pressure, we should only measure
the narcotic potency of nitrogen. Two other groups aimed
to activate the intrastriatal glutamatergic pathway by sti-
mulating NMDA-receptor by retrodialysis. One was devel-
oped as a control (_3_) and it was developed under
atmospheric pressure (n = 8), while the other (_4_) was
conducted under pressurized nitrogen (3MPa) (n = 6).
The two last groups (_5_6_) were similar to previous
experiment (under atmospheric and hyperbaric condition;
Figure 1 Stimulation of the main striatal projections involved
in nitrogen narcosis. Two microdialysis probes are presented on
the diagram to point out the stimulation points on the
glutamatergic ways. The aim is to enhance neurotransmitters release
and their metabolites in the striatum. A probe is schematized in the
striatum and the second one is in the prefrontal cortex. Measures of
citrulline arginine dopamine and glutamate are performed in the
striatum. SNr/iGP projects to thalamus with GABA-ergic neurons.
Thalamus essentially projects to striatum and cortex with
glutamatergic neurons. The compilation of these both pathways
virtually results in an inhibitory pathway, represented on the
diagram. Cortex and especially prefrontal cortex (PFC) essentially
project to striatum with glutamate as (excitatory) transmitter. SNc
projects to striatum using dopamine, but the effect on striatum
(inhibitory or excitatory) depends on the type of receptor: D1-like
(direct pathway; inhibitory) or D2-like (indirect pathway not shown:
excitatory). Using the direct pathway, striatum project to SNr/iGP
with GABA. DA, dopamine; GABA, gamma aminobutyric acid; Glu,
glutamate;PFC, prefrontal cortex; SNc, subtantia nigra pars
compacta; SNr/iGP, substantia nigra pars reticulata and internal
globus pallidus. Dotted arrows mark inhibitory pathways. Solid
arrows mark excitatory pathways.
Vallée et al. Medical Gas Research 2011, 1:16
http://www.medicalgasresearch.com/content/1/1/16
Page 2 of 10n = 9/9) except that the stimulation of the striatum was
conducted from the prefrontal cortex using a KCl solution.
Surgery
Anaesthesia was induced by halothane (5% with O2)
(Halothane
®, Belamont) and then deep anaesthesia was
prolonged with sodium pentobarbital (30 mg/kg, i.p.)
(Sanofi Santé Animal) and ketamine (0.40 mg/kg, i.m.;
Imalgène
® 500, Laboratoire Rhône-Mérieux). The rats
underwent stereotaxic implantation with intracerebral
guides (CMA/12 guide cannulae; Phymep, France): the
coordinates of the striatum (group 1 to 6) were inter-
aural; anterior 10.0 mm, lateral ± 2.8 mm, and height
6.4 mm; and those (group 5 and 6) for the prefrontal cor-
tex were inter-aural; anterior 13.0 mm, lateral ± 1.4 mm,
and height 8.4 mm, according to the Paxinos and Watson
brain atlas [34]. The disposition and number of probes
implanted depend on the stimulation.
Microdialysis in hyperbaric conditions
The microdialysis equipment consisted of micro-injector
pumps (CMA/102; Phymep, France) customized to sup-
port high pressure, a Raturn™ cage (Bioanalytical Systems,
Inc.) to prevent fluid lines tangling, and probes (CMA/12;
Phymep, France). Probes with a 3 mm long membrane
were used for striatal microdialysis, and probes with a
1 mm long membrane were used for retrodialysis in the
prefrontal cortex. HPLC switch valves, equipped with a
20 μl loop, were added to the microdialysis system, in
order to propel the dialysate into the refrigerated micro-
fraction collector (Univentor 820 Microsampler; Phymep,
France) placed outside the hyperbaric chamber. The
various components of the microdialysis devices were
interconnected using FEP-tubing (1.2 μL/10 cm) or PEEK-
tubing (1.3 μL/10 cm), and tubing adapters. The system
was infused with artificial cerebrospinal fluid (CSF in
mmol/L: NaCl 147, KCl 2.7, CaCl2 1.2, MgCl2 0.85). This
system was designed to collect regular samples in order to
freeze them as soon as possible, with no limitation on the
number of vials available in the collector if the latter was
placed inside the hyperbaric chamber [4].
The day before the experiment, new microdialysis
probes were rinsed for 20 minutes with 70% ethanol in
order to wash out the glycerol used for packaging. Each
probe was then connected to the inlet microdialysis line
for the hyperbaric chamber and checked for air bubbles.
Then, when connected to the outlet line, the entire dialysis
line was washed with CSF overnight. Between experi-
ments, the entire circuit was rinsed for at least one day,
with methanol/water (40/60) and then air-dried.
On the day of the experiment (Figure 2), at about
7:30 a.m., microdialysis probes were inserted into the
brains of the conscious rats. Extracellular striatal levels
of amino acids and monoamines were allowed to
reconstitute for 2 hours and 40 minutes before the
blank microdialysates (1 hour 20 minutes ® 4s a m -
ples) were considered as the basal value (baseline).
Striatum dialysates were collected every twenty min-
utes at the rate of 1 μl per minute (20 μl/dialysate)
and frozen.
Stimulation
Control rats and rats subjected to nitrogen narcosis had
an intracerebral guide implanted in the right striatum
infused with CSF.
For the intra-striatum stimulation with NMDA [5],
two syringes infused the two probes implanted in the
right and left striatum and liquid switch connectors
(CMA/110, Phymep France) made it possible to switch
manually between the two perfusion lines, one of which
contained the pharmacological agent for retrodialysis
(NMDA 2 mM, Sigma, France).
For the distal stimulation of the striatal glutamate
release [6], we stimulated the corticostriatal pathway
and more precisely the prefrontal cortex (PFC) [35-37]
with a depolarized concentration of potassium chloride
(KCl) and in the presence of local GABAb receptor
blockade-in order to have a long lasting effect of the
KCl-as inspired by Harte & O’Connor [38] protocol.
Two syringes infused the rat prefrontal cortex implanted
with two probes and liquid switch connectors (CMA/
110, Phymep France) made it possible to switch manu-
ally between the two perfusion lines, one of which con-
tained the pharmacological agent (Saclofen 1 mM and
Figure 2 Diving procedure. Following the insertion of the probes
into the brains, the rats were allowed a recovery time of 2 hours
and 40 minutes before the four blank microdialysates were
collected to establish the baseline. Each square represents one
dialysate sample collected every twenty minutes. The stimulation by
retrodialysis and the compression stage (or simili under atmospheric
pressure) began at the same time. Rats remained at the maximal
compression (or simili) for 3 hours. The dotted line marks the
pressure of the inert gas and the oxygen partial pressure.
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Page 3 of 10KCl 100 mM, Sigma, France). Another probe implanted
in the striatum for conventional dialysis was infused
with CSF.
Hyperbaric procedure
Striatum basal activities were monitored for 4 hours before
compression was started. The experiments were con-
ducted in a 150 L hyperbaric chamber fitted with three
viewing portholes. Rats were subjected to compression
(40 minutes ® 2 samples) at a rate of 0.01 MPa/minute
up to 0.1 MPa, and then at a rate of 0.1 MPa/minute up to
3 MPa. Monitoring was continued during the period spent
under pressure (3 hours ® 9 samples). Carbon dioxide
levels were kept below 300 ppm by continuous circulation
of gases in the chamber through a soda-lime canister.
Oxygen partial pressure was adjusted to 0.04 MPa (diving
quality oxygen, Air Liquide, France). A powerful fan
ensured that oxygen was well mixed with the gases added
to generate narcosis. Humidity (40-60%) was controlled
with silica gel, and the ambient temperature was adjusted
to 27°C [39], to prevent hypothermia and ensure that the
rodents remained comfortable. Lights were on. At the end
of the experiment, a lethal dose of nitrous oxide was
injected into the hyperbaric chamber and the decompres-
sion was performed.
In the atmospheric experiments, rats were anaesthetized
with halothane (5% with O2) (Halothane
®, Belamont) and
sacrificed by lethal injection of pentobarbital.
Apparatus and chromatography
Citrulline and arginine analyses. The microdialysis striatal
sample content was analysed by High Performance Liquid
Chromatography (Shimadzu, DGU-20A3 Degasser, LC-
20AB pump, SIL-10ADvp Autosampler, CBM-20A device
controller) coupled with fluorimetric detection (Shimadzu,
RF-10Axl Fluorescence Detector). HPLC was carried out
with a reverse phase C18 column (3 μm, 200 × 3 mm,
P h y m e p )s t a b i l i z e da t2 5 ° Cu sing gradient conditions,
according the following schedule: at 1.0 mL/min; first
12 min, 15% of eluent B; the concentration of B was raised
linearly to 28% in the next 20 min; then raised linearly to
70% in the next 35 min; and finally raised linearly to 80%
at the same flow rate until the chromatography was com-
pleted (80 min). Eluent A consisted of a sodium acetate
buffer (sodium acetate 0.01 M, 15% MeOH, triethylamine
2 mM, EDTA 0.3 mM, pH 9.3) and eluent B was similar
to eluent A but with the alcohol content adjusted to 45%
(sodium acetate 0.01 M, 45% MeOH, triethylamine 2 mM,
EDTA 0.3 mM, pH 9.3). Measurement of amino-acid
concentrations required pre-column derivatization (fixing
of a fluorophore to the sample to produce fluorescent
derivatives) with an ortho-phthaldialdehyde (OPA) reagent
(OPA 37 mM, 2-mercaptoethanol 128 mM, 25%
methanol, water, borax 24 mM, pH 10) mixed on line and
added to the dialysate (v/v).
Statistical Analysis
For each subject, the baseline was determined using the
four samples taken prior to gas pressure exposure. Sam-
ples were next expressed as a percentage of the baseline,
taken as the 100% value (baseline). Data for the whole
group was noted using median and the 25 and 75 percen-
tiles. Non-parametric statistical tests were used as the
number of animals was small. Firstly, baseline groups were
compared to the compression and exposure stages for
each experiment type and each molecule, with a Kruskal-
Wallis test followed by a Dunn test. The effects of striatum
stimulation were then compared under exposure to nitro-
gen and in atmospheric conditions for each molecule
development, and at each time point (Mann-Whitney
test).
A differentiation was made between exposure during
the period under compression (from 0.01 MPa to 3 MPa)
and the period spent at maximum pressure (3 MPa).
Results
In rat striatum, the medium concentrations of citrulline
and arginine during the control period, were 1.36 ± 0.34
and 7.64 ± 1.82 μM respectively, without taking probe
recovery into consideration.
Extracellular citrulline levels
Effects of nitrogen narcosis in the striatum
Exposure to pressurized nitrogen at 3 MPa (group 2)
induced a reduction in extracellular citrulline levels, com-
pared with the baseline (Table 1 and Figure 3A). The aver-
age decrease in citrulline reached 17.2% during the
maximum exposure to pressurized nitrogen. When com-
paring with the basal values, the same experiment con-
ducted under helium at 3 MPa (group 1) revealed
significantly higher citrulline levels during the compres-
sion stage (up to 3MPa) but not during the stay at the
maximal pressure. The maximal value reached 147.2%.
Nonetheless, a significant difference (delta 20.4%) was
noted when both experiments (group 1 vs. 2) were com-
pared. (Table 1 and Figure 3A).
Effects of a proximal stimulation on the striatum
In atmospheric conditions (0.01 MPa; group 3), and com-
pared with the baseline, NMDA infusion increased extra-
cellular citrulline levels from the start to the end of the
experiment. The increase in citrulline averaged 168.5%,
compared with the baseline, and it reached 187.7%.
When both conditions were combined, NMDA retrodia-
lysis and high nitrogen pressure (group 4), extracellular
citrulline levels remained unchanged from the compres-
sion stage to the end of the 3MPa period (Table 1 and
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Page 4 of 10Table 1 Comparison of the striatal citrulline baseline with its evolution in nitrogen at 3 MPa (n = 6), in helium at 3MPa (n = 8), at atmospheric pressure with
NMDA (2 mM) retrodialysis in the striatum (n = 8), or in nitrogen exposure with NMDA retrodialysis in the striatum (n = 6), at atmospheric pressure with KCL
(100 mM) and Saclofen (1 mM) retrodialysis in the PFC (n = 9), or in nitrogen exposure with KCL and Saclofen retrodialysis in the PFC (n = 9)
Citrulline Control groups 3MPa Nitrogen groups Comparison
Comp. 180 Minutes exposure Median (1
st _3
rd quartile) Comp. 180 Minutes exposure Median (1
st _3
rd quartile) p-value
p-value p-value post hoc test p-value p-value post hoc test comp Stay
Helium at 3MPa (1)/Nitrogen (2) n = 8/6 0.002 112.4 (91.3_151.7) 0.220 0.544 82.8 (67.5_97.7) 0.005 0.008 < 0.001
NMDA retrodialysis (3_4) n = 8/6 0.079 168.5 (142.7_216.3) < 0.001 0.720 94.3 (58.7_169.1) 0.327 0.939 < 0.001
PFC retrodialysis (5_6) n = 9/9 0.009 119.0 (100.0_150.8) 0.012 0.141 135.7 (84.1_167.1) 0.007 0.397 0.727
-1- Baselines and periods at maximum pressure (but not the compression stage) were described using median and quartile. -2- The citrulline baseline was compared to the compression stage (up to 3MPa-"Comp.”)
and to a maximum pressure period (at 3MPa, “180 Minutes exposure”) using a Kruskal-Wallis test (p-values were noted, a = 5%), followed by a post-hoc test transcribed by squares. Each square represents a string of
samples (~median value) that must be compared with the baseline samples, arranged in chronological order: 2 squares for 2 series of samples available during the compression stage (or simili); 9 squares for 9 series
of samples available during the period at the maximum pressure (or simili). Dark squares indicate a significant difference, as indicated by a post-hoc Dunn test (a = 5%), between samples at the corresponding time
point and its baseline. White squares indicate no significant difference between the string of samples at the corresponding time point and the baseline. The compression stages (up to 3MPa) and the maximum
pressure period (3MPa) of the control groups and the 3MPa nitrogen group were compared with each other, using a Kruskal-Wallis test (a = 5%). P-values were noted.
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0Figure 3A). Citrulline levels were significantly higher
when comparing values recorded during NMDA infusion
in the atmospheric pressure group (group 3) with those
recorded during nitrogen exposure with NMDA (group
4)(Table 1). Nonetheless, no significant difference was
found between compression phases (Table 1). In compar-
ison with the nitrogen exposure group (group 2), no sig-
nificant difference in citrulline levels was shown with the
nitrogen plus NMDA group (group 4) (during compres-
s i o n :n=6 / 6 ,p=0 . 5 7 1 ,a = 0.05; at 3MPa: n = 6/6, p =
0.225, a = 0.05).
Effects of a distal stimulation on the striatum
In atmospheric conditions (0.01 MPa) (group 5), and
compared with the baseline, the PFC infusion increased
extracellular citrulline levels from the start to the end of
the stimulation (Table 1 and Figure 3A). Citrulline levels
increased up to 119.0% compared with the baseline, and
the maximum value (151.3%) was reached at the end of
the experiment. In nitrogen at 3MPa with PFC retrodialy-
sis (group 6), and compared with the baseline, extracellu-
lar citrulline levels increased from the compression stage
t ot h ee n do ft h e3 M P ap e r i o d( T a b l e1a n dF i g u r e3 A ) .
The increase in citrulline reached +33.7% during the per-
iod of maximum nitrogen pressure (Figure 2A). No sig-
nificant difference was revealed when values recorded
during nitrogen exposure (compression phase and stage
at 3MPa) with PFC retrodialysis were compared with
those recorded during PFC retrodialysis in the atmo-
spheric pressure group (group 5 vs. 6) (Table 1). Data
recorded in pressurized nitrogen at 3MPa (group 2)
showed significantly lower citrulline levels than those
recorded in nitrogen with theP F Cs t i m u l a t i o n( g r o u p6 )
(n = 6/9; p < 0.001; a = 0.05); no significant difference is
shown between the compression stages (n = 6/9; p =
0.183; a = 0.05).
Extracellular arginine rates
Effects of nitrogen narcosis in the striatum
Exposure to pressurized nitrogen at 3 MPa (group 2)
induced a reduction in extracellular arginine levels, com-
pared with the baseline (Table 2 and Figure 3B). The
medium decrease in arginine reached 6.3% during the
maximum exposure to pressurized nitrogen pressure.
The same experiment conducted in helium at 3 MPa
(group 1) did not reveal significant changes in citrulline
levels, except during the transient compression stage,
which revealed an increase up to 147.2% (Table 2 and
Figure 3B).
Effects of a proximal stimulation on the striatum
In atmospheric conditions (0.01 MPa) (group 3), and
compared with the baseline, NMDA infusion increased
extracellular arginine levels, up to 145.7% on average
compared with the baseline. The level of the arginine
rapidly increases around 130% and it reached at the end
of the stimulation 154.8%. When both conditions were
combined (group 4), NMDA retrodialysis and high nitro-
gen pressure, a significant decrease was revealed in extra-
cellular arginine levels finishing at 53.0% in the 3MPa
period (Table 2 and Figure 3B). Arginine levels were
Figure 3 (A-B) Effects of an NMDA stimulation or a KCL and
Saclofen infusion under normobaric (n = 8/9) and high (n = 6/9)
nitrogen-oxygen pressure atmospheres on levels of
extracellular citrulline (A) and arginine (B) in the rat striatum.A
helium-oxygen (n = 8) mixture was used as the control in order to
evaluate the effect of pressure per se, and it was compared to the
nitrogen-oxygen (n = 6) mixture used in order to induce nitrogen
narcosis (effect of narcosis and pressure are linked). The ordinate of
each graph shows the median level of amino-acid expressed as the
percentage of the baseline level, which is the mean of the four
consecutive values observed immediately before the beginning of
the compression/infusion of NMDA (2 mM) or KCl (100 mM) and
Saclofen (1 mM). The time for compression (or simili) is shown by the
grey area, which is followed by the maximum pressure period, 3 MPa
(or simili). Dotted lines mark control experiments using helium at
3MPa or retrodialysis under atmospheric pressure. Lines mark
experiments conducted in nitrogen at 3 MPa. Intergroup
comparisons: strong signs in the corners of the graph indicate
significant change in the evolution of citrulline or arginine levels (a =
0.05, Kruskal-Wallis test) between the nitrogen group and the NMDA-
nitrogen group (#) or the KCl-Saclofen-nitrogen group (*). Small signs
# and * at the corresponding time point indicate significant changes
(a = 0.05, post hoc Dunn test) between the nitrogen group and the
NMDA-nitrogen group (#) or the KCl-Saclofen-nitrogen group.
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Page 6 of 10Table 2 Comparison of the striatal arginine baseline with its evolution in nitrogen at 3 MPa (n = 6), in helium at 3MPa (n = 8), at atmospheric pressure with
NMDA (2 mM) retrodialysis in the striatum (n = 8), or in nitrogen exposure with NMDA retrodialysis in the striatum (n = 6), at atmospheric pressure with KCL
(100 mM) and Saclofen (1 mM) retrodialysis in the PFC (n = 9), or in nitrogen exposure with KCL and Saclofen retrodialysis in the PFC (n = 9)
Arginine Control groups 3MPa Nitrogen groups Comparison
Comp. 180 Minutes exposure Median (1
st _3
rd quartile) Comp. 180 Minutes exposure Median (1
st _3
rd quartile) p-value
p-value p-value post hoc test p-value p-value post hoc test comp Stay
Helium at 3MPa (1)/Nitrogen (2) n = 8/6 0.031 100.8 (84.0_115.2) 0.820 0.895 93.7 (83.1_98.4) 0.031 0.008 < 0.001
NMDA retrodialysis (3_4) n = 8/6 0.113 131.8 (103.6_192.2) < 0.001 1.000 71.7 (46.3_121.1) 0.013 0.758 < 0.001
PFC retrodialysis (5_6) n = 9/9 0.141 21.3 (3.4_47.7) < 0.001 0.426 28.4 (8.1_62.4) < 0.001 0.709 0.188
-1- Baselines and periods at maximum pressure (but not the compression stage) were described using median and quartile. -2- The arginine baseline was compared with the compression stage (up to 3MPa-"Comp.”)
and to a maximum pressure period (at 3MPa-"180 minutes exposure”) using a Kruskal-Wallis test (p-values were noted, a = 5%), followed by a post-hoc test transcribed by squares. Each square represents a string of
samples (~median value) that must be compared with the baseline samples, arranged in chronological order: 2 squares for 2 series of samples available during the compression stage (or simili); 9 squares for 9 series
of samples available during the stay at the maximum pressure (or simili). Dark squares indicate a significant difference, as indicated by a post-hoc Dunn test (a = 5%), between samples at the corresponding time
point and its baseline. White squares indicate no significant difference between the string of samples at the corresponding time point and the baseline. The compression stages (up to 3MPa) and the maximum
pressure period (3MPa) of the control groups and the 3MPa nitrogen group were compared with each other, using a Kruskal-Wallis test (a = 5%). P-values were noted.
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0significantly lower when values recorded during NMDA
infusion in the atmospheric pressure group (group 3)
were compared with those recorded during nitrogen
exposure with NMDA (group 4) (Table 2). Nonetheless,
no significant difference was found between compression
phases (Table 2). The intergroup test (group 2 vs. 4)
highlighted no significant difference in arginine levels
when comparing the 3MPa nitrogen exposure group with
t h e3M P an i t r o g e ne x p o s u r ep l u sN M D Ag r o u p( n=6 /
6; p = 0.365; a = 0.05) (Figure 3A). No significant differ-
ence is shown between the compression stages (n = 6/6;
p = 0.571; a = 0.05) (Figure 3B).
Effects of distal stimulation on the striatum
In atmospheric conditions (group 5) (0.01 MPa), as in
nitrogen at 3MPa (group 6), and compared with the base-
line, the PFC infusion decreased extracellular arginine
levels (Table 2 and Figure 3B). Arginine levels decreased
by up to 21.3% (and 28.4% in pressurized nitrogen) com-
pared with the baseline, and minimum values (respectively
3.1% and 5.2%) were reached at the end of the experiment
(Table 2 and Figure 3B). No significant difference was
revealed when values recorded during nitrogen exposure
with PFC retrodialysis were compared with those recorded
during PFC retrodialysis in the atmospheric pressure
group (group 5 vs. 6) (Table 2), whatever the phase.
Nevertheless, values recorded in nitrogen at 3MPa com-
bined with the PFC stimulation (group 6) were signifi-
cantly lower than those recorded in nitrogen at 3MPa
(group 2) (n = 6/9; p < 0.001; a = 0.05), the latter being
lower than baseline values. No significant difference is
shown between the compression stages (n = 6/9; p =
0.231; a = 0.05) (Figure 3B).
Discussion
The main symptom of narcosis is major depletion in
neurotransmission expressedb yas i g n i f i c a n tr e d u c t i o n
in striatal dopamine and glutamate levels (Table 3). We
have now highlighted for the first time that extracellular
citrulline and arginine levels were also reduced by nitro-
gen at 3MPa.
Our observations reflected the balance between the
uptake and release processes of arginine and citrulline.
Therefore this should not be forgotten to appreciate NO
synthesis. L-citrulline is presently well accepted as a nitric
oxide index [32,40-43] as its production in the brain is
directly linked to the NO production. But the interpreta-
tion of the L-arginine extracellular concentration remains
discussed [24,27,43-47]. The arginine is not exclusive of
NO synthesis and citrulline, and it is also used at the same
time for other metabolic reactions [32]. Nonetheless,
under nitrogen at 3MPa, there is less citrulline available to
be recycled into arginine via the NO-citrulline cycle [29].
Hence, our discussion preferentially hinges on citrulline
results, even if arginine remains essential to the under-
standing of NO development under nitrogen narcosis.
Effect of nitrogen at 3MPa on striatal citrulline and
arginine levels
Helium control was used to dissociate the effect of pres-
sure from that of narcosis. Compared with nitrogen at
3MPa, helium at 3MPa does not induce narcosis, as it has
very low narcotic potency [1]. Under helium, we observed
a transitory increase-which disappeared at 3MPa-in citrul-
line and arginine levels that may be attributed to the varia-
tion of pressure. This short increase was not displayed
under nitrogen during the compression phase what show
the opposing effect of the narcotic gas action and the pres-
sure per se effect [4,48,49]. Hence the lowered extracellu-
lar concentrations of citrulline and arginine, recorded
under nitrogen, can be directly attributed to the effect of
the narcotic potency of the gas.
While gathering data recordings in nitrogen narcosis, we
firstly remarked that there is less glutamate for the potent
induction of NO and citrulline production from arginine.
Our previous paper highlighted that the NMDA-Receptor
was not directly affected by nitrogen under pressure and
the NMDA-activation should be able to activate NOS pro-
duction linked to NO/citrulline synthesis. Nonetheless, we
measured that striatal citrulline levels were not signifi-
cantly increased by NMDA retrodialysis in nitrogen
although it was in atmospheric conditions; neither were
the arginine levels increased. Moreover, the arginine levels
have shown no significant difference between data record-
ings in nitrogen, whether NMDA retrodialysis was used or
not. We should conclude that the NMDA-evoked citrul-
line and arginine increases were counteracted by nitrogen
narcosis once again, and that NO was not synthesized
despite the NMDA-Receptor stimulation. Although it was
not significant, graphics clearly show an increase in argi-
nine and citrulline levels at the beginning of the NMDA
stimulation that was counteracted when nitrogen raised
3MPa and its strongest narcotic effect. We should
Table 3 Overwiew of the effect of nitrogen at 3MPa on
rat striatal neurotransmitters, based on previous
literature and the current study
Levels of striatal ... DA Glu Cit-NO
Basal effect of nitrogen at 3MPa ... down down down
... with NMDA retrodialysis up down down
compared to the basal effect more same same
... with PFC retrodialysis down down up
compared to the basal effect same same more
Effects are reported after exposure to pressurized nitrogen at 3MPa for
dopamine (DA), glutamate (Glu) and citrulline (Cit-NO) levels. DA and Glu
levels refer to previous studies [4-6]. We considered citrulline as a good index
of nitric oxide (NO) levels in the brain. The effect of nitrogen at 3MPa
comparing basal values in atmospheric ambiance is noted in bold letters. The
comparison between the basal effect of nitrogen at 3MPa and its effect
combined with a chemical stimulation by retrodialysis is noted in italic letters.
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NO synthesis.
Nevertheless, taking into consideration both PFC-stimu-
lation experiments conducted under pressurized nitrogen
or not, extracellular citrulline and arginine levels remained
unchanged. The striatal citrulline level remains raised and
the striatal arginine levels remains reduced, while the glu-
tamate levels were strongly reduced. This last comment
led to reconsideration of the previous conclusion indicat-
ing that the citrulline increase can be counteracted by
pressurized nitrogen. That is to say, NO/citrulline synth-
esis is possible in nitrogen at 3MPa and the mechanism
involved in the citrulline decrease recorded in nitrogen
narcosis is not directly affected by the gas. There could be
a factor which is able to activate NOS activity while the
PFC was stimulated but is not involved when using stria-
tum-NMDA stimulation.
Effect on neurotransmitter release
Briefly, in conventional conditions but not in nitrogen nar-
cosis, the strong NMDA-R stimulation promotes dopa-
mine, glutamate and citrulline/NO increases, due to the
fact that NO synthesis is under glutamate control and
dopamine regulation. As a result of these reduced levels,
NO cannot enhance neurotransmitter exocytosis, and
more particularly glutamate exocytosis at the presynaptic
level. It could lead to a weak activity of thalamostriate and
corticostriate pathways involving those nitrogen narcosis
symptoms.
In other words, an increase in NO level, that is NMDA-
dependent, could partly manage a decrease in synaptic
vesicle endocytosis and later stages of recycling [13,25].
Hence, NMDA-evoked NO production could partly
increase extracellular dopamine and glutamate levels.
This status seems to be in accordance with the NMDA
experiments. PFC stimulation results were also in accor-
dance with such a hypothesis: in nitrogen exposure there
was no more glutamate available for a NMDA-induced
NO release, itself inhibiting DA re-uptake, but there was
no dopamine available for recycling or being broken
down into DOPAC (dihydroxyphenylacetic acid) and
HVA (homovanillic acid).
Arginine availability, which is dependent on the acti-
vation of ionotropic non-NMDA receptors, controls the
NMDA-induced nitric oxide synthesis: the arginine
transfer from glial cells takes place on activation of glial
ionotropic non-NMDA receptors and the predominant
glial localization of arginine [27]. In narcosis, glutamate
is not available for stimulating non-NMDA-Receptors
and this lack could limit the arginine shuttle.
Effect on basal ganglia pathways
This study was conducted in the striatum in charge of
motor and cognitive function. It is the primary input
nucleus of the basal ganglia which impinge on the
whole basal ganglia pathways. We now highlight rat
hypoactivity under nitrogen narcosis is concomitant to
low levels of main striatal neurotransmitters (Table 3).
The motor and locomotor disruptions recorded under
nitrogen at 3MPa are linked to dopamine glutamate and
a potent NO decreases, in regards of citrulline and argi-
nine levels. The low glutamate release of corticostriate
and thalamostriate projections, the principal glutamater-
gic striatal afferents, could now be linked to a sensitiza-
tion of the NMDA receptor [18-20] in relation with the
NO decrease. This could represent another retrograde
regulation of postsynaptic zone [13] in the striatum.
Conclusion
The current study was undertaken to examine the impact
of nitrogen under pressure on the NO pathway, and to
focus on glutamate and dopamine reduction in narcosis.
We demonstrated that a reduction of striatal glutamate
and dopamine levels recorded in nitrogen narcosis was
coupled to a decrease in levels of arginine, the NO precur-
sor, and of citrulline, the NO co-product. We suspected
an NO decrease under nitrogen narcosis. Therefore, in
narcosis glutamate is not available for stimulating either
the non-NMDA or NMDA-receptors. Hence there is no
glutamate-induced NMDA-R dependent NO synthesis
and NO cannot enhance the strength of the glutamate sig-
nal spreading across basal ganglia pathways. Based on this
evidence, we also conclude that the arginine shuttle
between glial cells and neurons should not be able to sup-
ply arginine for citrulline/NO production. Nevertheless,
we highlighted the glutamate-independent possibility of
a citrulline/NO synthesis, but without identifying the miss-
ing key.
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